This study investigated the effects of prenatal herbal methionine supplementation on growth, puberty onset, reproductive efficiency, and blood metabolites in first-generation G1 Alpine doelings. Sixty pregnant multiparous goats (G0), each with at least three parturitions, were assigned during the last trimester of pregnancy to either herbal methionine (H-MET-G0; 1% Optimethione^®; n = 30) or a control group (CTL-G0; n = 30). Only female offspring (G1 doelings) were studied (H-MET-G1:19; CTL-G1:25) from weaning (45 days old) to 10 months (first breeding). G1 doelings were weighed and monitored weekly for metabolites, IGF-1, insulin, and progesterone. Ovulation of the G1 doelings was induced using vasectomized bucks, followed by breeding with intact bucks. Postweaning growth, age at puberty (H-MET-G1:216 vs. CTL-G1:229 days), and live weight at puberty (H-MET-G1:20.5 vs. CTL-G1:21.0 kg) did not significantly differ (p > 0.05). Age at puberty and conception were negatively correlated with live weight (p < 0.001). First-cycle conception rates were 81% in CTL-G1 and 66% in H-MET-G1, with similar days to conception (p > 0.05). The number of pregnant doelings and the number of kids in utero did not significantly differ (p > 0.05) between treatments. Plasma IGF-1 and insulin levels were significantly higher (p < 0.001) in H-MET-G1 doelings, whereas plasma metabolites related to nutrition showed no differences between groups (p > 0.05). Prenatal herbal methionine supplementation had no carry-over effect on growth, puberty onset, or reproductive efficiency. Age at puberty and conception were negatively correlated with live weight and positively correlated with IGF-1 and insulin levels.

Kalanchoe daigremontiana, a medicinal plant rich in bioactive compounds, has the potential to serve as a feed supplement, reducing reliance on conventional livestock medications while potentially enhancing productivity. This study evaluated the effects of K. daigremontiana supplementation over 52 days on kidney and liver function, metabolism, weight changes, and reproductive efficiency in multiparous Alpine goats during the breeding season. Fifty-five goats were assigned to either a control (CTL, n = 27; 47.6 ± 1.1 kg) or a K. daigremontiana-supplemented (KAL, n = 28; 47.6 ± 1.3 kg) diet. The KAL group received K. daigremontiana at a dry matter-based inclusion rate of 2 kg t⁻¹ of feed, while the CTL group received no supplementation. Blood samples were collected at four time points to assess the biochemical markers of kidney and liver function. Pregnancy was achieved through natural mating, and reproductive efficiency was evaluated. Overall, liver and kidney function did not differ significantly between treatments (p > 0.05). However, KAL supplementation was associated with increased creatinine (p < 0.05), ALP (p < 0.001), and bilirubin (p < 0.05) at specific time points, whereas CTL goats exhibited higher BUN (p < 0.001), AST (p < 0.05), albumin (p < 0.001), total protein (p ≤ 0.05), and phosphorus (p < 0.01) on specific dates. Other metabolic markers, weight gain, and reproductive efficiency did not differ between treatments (p > 0.05). Overall, Kalanchoe daigremontiana supplementation had mild, transient effects on goat health without significantly impacting productivity. Further research is needed to explore its long-term effects and optimal dosage for livestock nutrition.

Goats in subtropical and temperate regions experience seasonal anestrus during long-day conditions. This study evaluated the effects of bee pollen (BP) supplementation on circulating metabolic and endocrine measures, plasma short-chain fatty acids (SCFAs), and reproductive outcomes. Thirty crossbred Spanish × Boer does were assigned to T-CTL (n = 15) or T-BP (n = 15). After a 7-day adaptation period, T-BP received 10 g/day BP for 42 days (approximately 0.31 g/kg initial body weight/day), while T-CTL received carrier feed alone. We measured plasma glucose, insulin, insulin-like growth factor 1 (IGF-1), progesterone (P4), and SCFAs. BP supplementation did not significantly (p > 0.05) alter plasma glucose, insulin, IGF-1, or overall P4 concentrations. Only five does became pregnant (T-BP, 2/15; T-CTL, 3/15); therefore, fertility, prolificacy, and reproductive rate were summarized descriptively. Most plasma SCFAs did not show a consistent treatment-dependent temporal response. Isovalerate showed a significant treatment × date interaction, whereas hexanoate differed overall between treatments without a significant treatment × date interaction. Under this single-dose protocol, BP did not consistently modify circulating metabolic–endocrine markers or improve reproductive performance during the suboptimal breeding season. Future studies should include dose-ranging, direct rumen measurements, and adequately powered reproductive endpoints.